| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |